Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

These ASX shares are starting the week strongly.

| More on:
An investor sits at her desk and stretches her arms above her head in delight.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a disappointing decline. The benchmark index is currently down 0.9% to 7,272.1 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

Baby Bunting Group Ltd (ASX: BBN)

The Baby Bunting share price is up 9% to $2.28. Investors have been buying this baby products retailer's shares after analysts at Morgans upgraded them to an add rating with a $2.50 price target. The broker made the move after increasing its earnings estimates to reflect cost reductions and a better sales outlook.

Carsales.Com Ltd (ASX: CAR)

The Carsales share price is up 6% to $26.11. This follows the release of the auto listings company's FY 2023 results. Carsales reported an 18% increase in pro forma revenue and a 43% lift in adjusted net profit after tax to $278.2 million. Looking ahead, management expects "to deliver good growth in Revenue and [pro forma] EBITDA in FY24" and an "expansion in the carsales Group EBITDA margin."

GWA Group Ltd (ASX: GWA)

The GWA share price is up 7% to $2.06. This has been driven by the release of the building fittings company's full-year results. GWA reported a 22.7% increase in statutory net profit to $43.2 million. Management commented: "GWA delivered a solid result for FY23 within a rapidly evolving operating environment that comprised two distinct halves."

Imugene Limited (ASX: IMU)

The Imugene share price is up 3.5% to 9.2 cents. This morning, this immuno-oncology company announced that its Phase 1 MAST (metastatic advanced solid tumours) trial evaluating the safety of novel cancer-killing virus CF33- hNIS (VAXINIA) has cleared the cohort 3 intratumoral (IT) arm of the monotherapy dose escalation study.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Carsales.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX 200 stocks marching higher this week even as the market sinks

These five ASX 200 companies are shrugging off the broader selling to march higher this week.

Read more »

Rising share price chart.
Share Gainers

Why Novonix, HMC, Karoon Energy, and Ventia shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Share Gainers

3 top ASX 200 stocks I wish I'd owned in 2024

These three top ASX 200 stocks are racing higher in 2024.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today

These shares are avoiding the market selloff on Thursday. But why?

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended up snatching defeat from the jaws of victory today.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »